Home
LQDA
LQDA News

Latest Liquidia Corporation (LQDA) News on November 24, 2024

3 US Growth Stocks With At Least 10% Insider Ownership

Simply Wall St.

5 days ago

3 US Growth Stocks With At Least 10% Insider Ownership

Liquidia Third Quarter 2024 Earnings: Beats Expectations

Simply Wall St.

9 days ago

Liquidia Third Quarter 2024 Earnings: Beats Expectations

Liquidia Corp (LQDA) Q3 2024 Earnings Call Highlights: Strategic Advances Amidst Regulatory ...

GuruFocus.com

10 days ago

Liquidia Corp (LQDA) Q3 2024 Earnings Call Highlights: Strategic Advances Amidst Regulatory ...

Liquidia Technologies, Inc. (LQDA) Reports Q3 Loss, Tops Revenue Estimates

Zacks

11 days ago

Liquidia Technologies, Inc. (LQDA) Reports Q3 Loss, Tops Revenue Estimates

Liquidia Corporation Reports Third Quarter 2024 Financial Results and Provides Corporate Update

GlobeNewswire

11 days ago

Liquidia Corporation Reports Third Quarter 2024 Financial Results and Provides Corporate Update

Liquidia to Present at the Stifel 2024 Healthcare Conference

GlobeNewswire

12 days ago

Liquidia to Present at the Stifel 2024 Healthcare Conference

Earnings To Watch: Liquidia Corp (LQDA) Reports Q3 2024 Result

GuruFocus.com

16 days ago

Earnings To Watch: Liquidia Corp (LQDA) Reports Q3 2024 Result

Arcellx (ACLX) Stock Jumps 6.7%: Will It Continue to Soar?

Zacks

17 days ago

Arcellx (ACLX) Stock Jumps 6.7%: Will It Continue to Soar?

Investors in Liquidia (NASDAQ:LQDA) have seen stellar returns of 186% over the past five years

Simply Wall St.

17 days ago

Investors in Liquidia (NASDAQ:LQDA) have seen stellar returns of 186% over the past five years

Liquidia Corporation to Report Third Quarter 2024 Financial Results on November 13, 2024

GlobeNewswire

18 days ago

Liquidia Corporation to Report Third Quarter 2024 Financial Results on November 13, 2024

Liquidia Corporation to Report Third Quarter 2024 Financial Results on November 11, 2024

GlobeNewswire

20 days ago

Liquidia Corporation to Report Third Quarter 2024 Financial Results on November 11, 2024

Will Y-mAbs Therapeutics, Inc. (YMAB) Report Negative Earnings Next Week? What You Should Know

Zacks

23 days ago

Will Y-mAbs Therapeutics, Inc. (YMAB) Report Negative Earnings Next Week? What You Should Know

Liquidia Technologies, Inc. (LQDA) Expected to Beat Earnings Estimates: What to Know Ahead of Q3 Release

Zacks

a month ago

Liquidia Technologies, Inc. (LQDA) Expected to Beat Earnings Estimates: What to Know Ahead of Q3 Release

3 US Growth Stocks With High Insider Ownership And Earnings Growth Up To 61%

Simply Wall St.

a month ago

3 US Growth Stocks With High Insider Ownership And Earnings Growth Up To 61%

MT Newswires

a month ago

Scotiabank Initiates Liquidia at Sector Outperform With $30 Price Target

Liquidia Corp (LQDA) Q2 2024 Earnings Call Highlights: Navigating Challenges and Opportunities ...

GuruFocus.com

a month ago

Liquidia Corp (LQDA) Q2 2024 Earnings Call Highlights: Navigating Challenges and Opportunities ...

Liquidia Technologies (LQDA) Surges 11.2%: Is This an Indication of Further Gains?

Zacks

2 months ago

Liquidia Technologies (LQDA) Surges 11.2%: Is This an Indication of Further Gains?

MT Newswires

2 months ago

Liquidia Shares Jump After US Supreme Court Rejects United Therapeutics' Appeal in Patent Dispute

United States Supreme Court Declines to Review Rulings that Invalidate United Therapeutics’ Patent

GlobeNewswire

2 months ago

United States Supreme Court Declines to Review Rulings that Invalidate United Therapeutics’ Patent

MT Newswires

2 months ago

Liquidia Expands Exclusive Licensing Agreement with Pharmosa Biopharm

Liquidia and Pharmosa Biopharm Expand Collaboration to Develop Sustained Release Inhaled Treprostinil (L606)

GlobeNewswire

2 months ago

Liquidia and Pharmosa Biopharm Expand Collaboration to Develop Sustained Release Inhaled Treprostinil (L606)

Liquidia Announces Poster Presentation and Medical Theater at the CHEST 2024 Annual Meeting

GlobeNewswire

2 months ago

Liquidia Announces Poster Presentation and Medical Theater at the CHEST 2024 Annual Meeting

Travere (TVTX) Soars 5.9%: Is Further Upside Left in the Stock?

Zacks

2 months ago

Travere (TVTX) Soars 5.9%: Is Further Upside Left in the Stock?

MT Newswires

2 months ago

Liquidia Says United Therapeutics' Interference Found by US Court to Have Caused Losses of Over $137 Million

With 38% ownership in Liquidia Corporation (NASDAQ:LQDA), institutional investors have a lot riding on the business

Simply Wall St.

2 months ago

With 38% ownership in Liquidia Corporation (NASDAQ:LQDA), institutional investors have a lot riding on the business

Court Finds United Therapeutics’ Interference with Launch of Generic Treprostinil Injection Caused Losses of More Than $137 Million

GlobeNewswire

2 months ago

Court Finds United Therapeutics’ Interference with Launch of Generic Treprostinil Injection Caused Losses of More Than $137 Million

GuruFocus.com

2 months ago

Caligan Partners LP Bolsters Portfolio with Significant Stake in Liquidia Corp

Liquidia Technologies (LQDA) Soars 14.1%: Is Further Upside Left in the Stock?

Zacks

2 months ago

Liquidia Technologies (LQDA) Soars 14.1%: Is Further Upside Left in the Stock?

MT Newswires

2 months ago

Liquidia to Raise $67.5 Million From Public Offering, Private Placement of Shares

Liquidia Corporation Announces Raise of $67.5 Million from New Common Stock Financings and $32.5 Million Advance from HealthCare Royalty Under Current Financing Agreement

GlobeNewswire

2 months ago

Liquidia Corporation Announces Raise of $67.5 Million from New Common Stock Financings and $32.5 Million Advance from HealthCare Royalty Under Current Financing Agreement

MT Newswires

3 months ago

Liquidia Seeks Stay on FDA Exclusivity Approval of Rival Version of Hypertension Drug

Liquidia to Present at Upcoming Investor Conferences

GlobeNewswire

3 months ago

Liquidia to Present at Upcoming Investor Conferences

Jim Cramer Says Liquidia Corporation (LQDA) Has Been Going ‘Down, Down, Down’

Insider Monkey

3 months ago

Jim Cramer Says Liquidia Corporation (LQDA) Has Been Going ‘Down, Down, Down’

MT Newswires

3 months ago

Liquidia Files Legal Challenge Against FDA Decision to Grant 3-Year New Clinical Investigation Exclusivity to Tyvaso DPI

Liquidia Files Litigation to Challenge Regulatory Exclusivity Blocking Access to YUTREPIA™ (treprostinil) inhalation powder for Patients Suffering with PAH and PH-ILD

GlobeNewswire

3 months ago

Liquidia Files Litigation to Challenge Regulatory Exclusivity Blocking Access to YUTREPIA™ (treprostinil) inhalation powder for Patients Suffering with PAH and PH-ILD

Biotech Stock Roundup: CRL for REGN, GILD's Drug Approval, LQDA Down on News

Zacks

3 months ago

Biotech Stock Roundup: CRL for REGN, GILD's Drug Approval, LQDA Down on News

Liquidia (LQDA) Down on FDA Delaying Full Approval for Yutrepia

Zacks

3 months ago

Liquidia (LQDA) Down on FDA Delaying Full Approval for Yutrepia

Liquidia’s YUTREPIA inhalation powder gains tentative FDA approval

Pharmaceutical Technology

3 months ago

Liquidia’s YUTREPIA inhalation powder gains tentative FDA approval

Why Liquidia Stock Just Reversed Its Seven-Day Sprint And Crashed 31%

Investor's Business Daily

3 months ago

Why Liquidia Stock Just Reversed Its Seven-Day Sprint And Crashed 31%

MT Newswires

3 months ago

Top Midday Decliners

MT Newswires

3 months ago

Sector Update: Health Care

MT Newswires

3 months ago

Liquidia's Hypertension Treatment Gains Tentative FDA Approval

Investing.com

3 months ago

Estee Lauder, Liquidia, B. Riley fall premarket; AMD rises

3 US Growth Companies With High Insider Ownership

Simply Wall St.

3 months ago

3 US Growth Companies With High Insider Ownership

U.S. FDA Grants Tentative Approval of YUTREPIA™ (treprostinil) Inhalation Powder for Patients with Pulmonary Arterial Hypertension (PAH) and Pulmonary Hypertension Associated with Interstitial Lung Disease (PH-ILD)

GlobeNewswire

3 months ago

U.S. FDA Grants Tentative Approval of YUTREPIA™ (treprostinil) Inhalation Powder for Patients with Pulmonary Arterial Hypertension (PAH) and Pulmonary Hypertension Associated with Interstitial Lung Disease (PH-ILD)

MT Newswires

3 months ago

Raymond James Initiates Coverage on Liquidia With Outperform Rating, $27 Price Target

Liquidia Announces Poster Presentations at the PHA 2024 International PH Conference and Scientific Sessions

GlobeNewswire

3 months ago

Liquidia Announces Poster Presentations at the PHA 2024 International PH Conference and Scientific Sessions

Liquidia Corporation (NASDAQ:LQDA) Analysts Are Cutting Their Estimates: Here's What You Need To Know

Simply Wall St.

3 months ago

Liquidia Corporation (NASDAQ:LQDA) Analysts Are Cutting Their Estimates: Here's What You Need To Know

Why Is Liquidia Corporation (LQDA) The Best Among Caligan Partners’ Top Holdings?

Insider Monkey

3 months ago

Why Is Liquidia Corporation (LQDA) The Best Among Caligan Partners’ Top Holdings?

Analysts Just Slashed Their Liquidia Corporation (NASDAQ:LQDA) EPS Numbers

Simply Wall St.

3 months ago

Analysts Just Slashed Their Liquidia Corporation (NASDAQ:LQDA) EPS Numbers

Liquidia Technologies, Inc. (LQDA) Reports Q2 Loss, Lags Revenue Estimates

Zacks

4 months ago

Liquidia Technologies, Inc. (LQDA) Reports Q2 Loss, Lags Revenue Estimates

Liquidia Corporation Reports Second Quarter 2024 Financial Results and Provides Corporate Update

GlobeNewswire

4 months ago

Liquidia Corporation Reports Second Quarter 2024 Financial Results and Provides Corporate Update

Puma Biotech (PBYI) Reports Q2 Loss, Tops Revenue Estimates

Zacks

4 months ago

Puma Biotech (PBYI) Reports Q2 Loss, Tops Revenue Estimates

IDEAYA Biosciences, Inc. (IDYA) Expected to Beat Earnings Estimates: Should You Buy?

Zacks

4 months ago

IDEAYA Biosciences, Inc. (IDYA) Expected to Beat Earnings Estimates: Should You Buy?

Liquidia Corporation to Report Second Quarter 2024 Financial Results on August 7, 2024

GlobeNewswire

4 months ago

Liquidia Corporation to Report Second Quarter 2024 Financial Results on August 7, 2024

High Insider Ownership Marks These US Growth Companies For July 2024

Simply Wall St.

4 months ago

High Insider Ownership Marks These US Growth Companies For July 2024

MT Newswires

5 months ago

Oppenheimer Initiates Liquidia at Perform

High Insider Ownership Growth Companies On US Exchange For June 2024

Simply Wall St.

5 months ago

High Insider Ownership Growth Companies On US Exchange For June 2024

Liquidia Announces Poster Presentations at the 7th World Symposia on Pulmonary Hypertension (WSPH)

GlobeNewswire

5 months ago

Liquidia Announces Poster Presentations at the 7th World Symposia on Pulmonary Hypertension (WSPH)

Liquidia Insiders Placed Bullish Bets Worth US$3.00m

Simply Wall St.

5 months ago

Liquidia Insiders Placed Bullish Bets Worth US$3.00m

Liquidia Stock Surges After Winning Patent Battle Vs. United Therapeutics

Investor's Business Daily

6 months ago

Liquidia Stock Surges After Winning Patent Battle Vs. United Therapeutics

MT Newswires

6 months ago

Liquidia's Yutrepia Launch Cleared as Court Denies Injunction

District Court Issues Favorable Ruling and Denies United Therapeutics’ Request to Block YUTREPIA™ Launch

GlobeNewswire

6 months ago

District Court Issues Favorable Ruling and Denies United Therapeutics’ Request to Block YUTREPIA™ Launch

Liquidia Corporation to Present at the 2024 Jefferies Global Healthcare Conference

GlobeNewswire

6 months ago

Liquidia Corporation to Present at the 2024 Jefferies Global Healthcare Conference

3 US Growth Companies With Insider Ownership As High As 27%

Simply Wall St.

6 months ago

3 US Growth Companies With Insider Ownership As High As 27%

GuruFocus.com

6 months ago

Liquidia Corp (LQDA) Q1 2024 Earnings Call Transcript Highlights: A Detailed Review of ...

Thomson Reuters StreetEvents

6 months ago

Q1 2024 Liquidia Corp Earnings Call

Liquidia (NASDAQ:LQDA) shareholders have earned a 64% CAGR over the last three years

Simply Wall St.

6 months ago

Liquidia (NASDAQ:LQDA) shareholders have earned a 64% CAGR over the last three years

Down -11.26% in 4 Weeks, Here's Why You Should You Buy the Dip in Liquidia Technologies (LQDA)

Zacks

6 months ago

Down -11.26% in 4 Weeks, Here's Why You Should You Buy the Dip in Liquidia Technologies (LQDA)

Liquidia Corporation Reports First Quarter 2024 Financial Results and Provides Corporate Update

GlobeNewswire

6 months ago

Liquidia Corporation Reports First Quarter 2024 Financial Results and Provides Corporate Update

Liquidia Announces Poster Presentation at the American Thoracic Society (ATS) 2024 International Conference on Its Open-Label Safety Study of L606 (Liposomal Treprostinil) in Patients with PAH and PH-ILD

GlobeNewswire

6 months ago

Liquidia Announces Poster Presentation at the American Thoracic Society (ATS) 2024 International Conference on Its Open-Label Safety Study of L606 (Liposomal Treprostinil) in Patients with PAH and PH-ILD

Liquidia Corporation to Present at BofA Securities Health Care Conference 2024

GlobeNewswire

7 months ago

Liquidia Corporation to Present at BofA Securities Health Care Conference 2024

Liquidia Corporation to Report First Quarter 2024 Financial Results on May 14, 2024

GlobeNewswire

7 months ago

Liquidia Corporation to Report First Quarter 2024 Financial Results on May 14, 2024

Will Editas Medicine (EDIT) Report Negative Q1 Earnings? What You Should Know

Zacks

7 months ago

Will Editas Medicine (EDIT) Report Negative Q1 Earnings? What You Should Know

Earnings Preview: Liquidia Technologies, Inc. (LQDA) Q1 Earnings Expected to Decline

Zacks

7 months ago

Earnings Preview: Liquidia Technologies, Inc. (LQDA) Q1 Earnings Expected to Decline

When Will Liquidia Corporation (NASDAQ:LQDA) Become Profitable?

Simply Wall St.

7 months ago

When Will Liquidia Corporation (NASDAQ:LQDA) Become Profitable?

Liquidia Corporation (NASDAQ:LQDA) has caught the attention of institutional investors who hold a sizeable 38% stake

Simply Wall St.

8 months ago

Liquidia Corporation (NASDAQ:LQDA) has caught the attention of institutional investors who hold a sizeable 38% stake

Liquidia Corporation to Present at 23rd Annual Needham Virtual Healthcare Conference

GlobeNewswire

8 months ago

Liquidia Corporation to Present at 23rd Annual Needham Virtual Healthcare Conference

Update on Favorable Legal and Regulatory Outcomes Clearing Path for Potential FDA approval of YUTREPIA™ (treprostinil) inhalation powder

GlobeNewswire

8 months ago

Update on Favorable Legal and Regulatory Outcomes Clearing Path for Potential FDA approval of YUTREPIA™ (treprostinil) inhalation powder

Chief Medical Officer Rajeev Saggar Sells Shares of Liquidia Corp (LQDA)

GuruFocus.com

8 months ago

Chief Medical Officer Rajeev Saggar Sells Shares of Liquidia Corp (LQDA)

Insider Sell: CFO and COO Michael Kaseta Sells 12,166 Shares of Liquidia Corp (LQDA)

GuruFocus.com

8 months ago

Insider Sell: CFO and COO Michael Kaseta Sells 12,166 Shares of Liquidia Corp (LQDA)

Liquidia Corporation (NASDAQ:LQDA) Q4 2023 Earnings Call Transcript

Insider Monkey

8 months ago

Liquidia Corporation (NASDAQ:LQDA) Q4 2023 Earnings Call Transcript

Liquidia Full Year 2023 Earnings: Misses Expectations

Simply Wall St.

8 months ago

Liquidia Full Year 2023 Earnings: Misses Expectations

Thomson Reuters StreetEvents

8 months ago

Q4 2023 Liquidia Corp Earnings Call

Liquidia Corp (LQDA) Reports Full Year 2023 Financial Results

GuruFocus.com

8 months ago

Liquidia Corp (LQDA) Reports Full Year 2023 Financial Results

Liquidia Technologies, Inc. (LQDA) Reports Q4 Loss, Lags Revenue Estimates

Zacks

8 months ago

Liquidia Technologies, Inc. (LQDA) Reports Q4 Loss, Lags Revenue Estimates

Liquidia Corporation Reports Full Year 2023 Financial Results and Provides Corporate Update

GlobeNewswire

8 months ago

Liquidia Corporation Reports Full Year 2023 Financial Results and Provides Corporate Update

Earnings Preview: Pliant Therapeutics, Inc. (PLRX) Q4 Earnings Expected to Decline

Zacks

9 months ago

Earnings Preview: Pliant Therapeutics, Inc. (PLRX) Q4 Earnings Expected to Decline

Liquidia Corporation to Report Full Year 2023 Financial Results on Wednesday, March 13, 2024

GlobeNewswire

9 months ago

Liquidia Corporation to Report Full Year 2023 Financial Results on Wednesday, March 13, 2024

Arbutus Biopharma (ABUS) Reports Q4 Loss, Misses Revenue Estimates

Zacks

9 months ago

Arbutus Biopharma (ABUS) Reports Q4 Loss, Misses Revenue Estimates

United Therapeutics (UTHR) Q4 Earnings & Sales Beat Estimates

Zacks

9 months ago

United Therapeutics (UTHR) Q4 Earnings & Sales Beat Estimates

United Therapeutics' Challenges FDA Over Liquidia's Drug Approval Process, Clocks Strong Q4 Earnings

Benzinga

9 months ago

United Therapeutics' Challenges FDA Over Liquidia's Drug Approval Process, Clocks Strong Q4 Earnings

Reuters

9 months ago

UPDATE 2-United Therapeutics files litigation with FDA over rival Liquidia's drug application

United Therapeutics, in unusual step, sues FDA over rival’s drug application

BioPharma Dive

9 months ago

United Therapeutics, in unusual step, sues FDA over rival’s drug application

Strength Seen in AnaptysBio, Inc. (ANAB): Can Its 5.9% Jump Turn into More Strength?

Zacks

9 months ago

Strength Seen in AnaptysBio, Inc. (ANAB): Can Its 5.9% Jump Turn into More Strength?

Greenbrier Companies (NYSE:GBX) shareholders have earned a 53% return over the last year

Simply Wall St.

10 months ago

Greenbrier Companies (NYSE:GBX) shareholders have earned a 53% return over the last year

Why It Might Not Make Sense To Buy Hope Bancorp, Inc. (NASDAQ:HOPE) For Its Upcoming Dividend

Simply Wall St.

10 months ago

Why It Might Not Make Sense To Buy Hope Bancorp, Inc. (NASDAQ:HOPE) For Its Upcoming Dividend

With 80% ownership of the shares, Safety Insurance Group, Inc. (NASDAQ:SAFT) is heavily dominated by institutional owners

Simply Wall St.

10 months ago

With 80% ownership of the shares, Safety Insurance Group, Inc. (NASDAQ:SAFT) is heavily dominated by institutional owners

UPDATE 2-Goldman Sachs shuffles management committee - WSJ

Reuters

10 months ago

UPDATE 2-Goldman Sachs shuffles management committee - WSJ

Why Cimpress Stock Skyrocketed Today

Motley Fool

10 months ago

Why Cimpress Stock Skyrocketed Today

Share on Social Networks: